Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Neurology
Published in: Current Treatment Options in Neurology 11/2018

01-11-2018 | Sleep Disorders (A Iranzo, Section Editor)

Sleep Abnormalities in Wilson’s Disease

Authors: Valérie Cochen De Cock, MD, PhD, Nadège Girardot-Tinant, PhD, France Woimant, MD, Aurélia Poujois, MD, PhD

Published in: Current Treatment Options in Neurology | Issue 11/2018

Login to get access

Abstract

Purpose of review

The aim of this article was to review the different sleep disorders associated with Wilson’s disease (WD), their mechanisms and their treatments.

Recent findings

Some of these disorders such as REM sleep behavior disorder or sleepiness can appear as a prodromal phase phenomenon in WD allowing an early treatment of the disease and sometimes a resolution of the sleep disorder.

Summary

Sleep disorders in WD are frequent combining insomnia, daytime sleepiness, restless legs syndrome (RLS), cataplexy-like episodes, and REM sleep behavior disorder (RBD). Sleep recordings confirm these disorders. Mechanisms involved in these disorders are complex associating (a) lesions of the pathways regulating sleep and wake or mood but also controlling movement, (b) iatrogenic effects of the treatments, and (3) consequences of the motor or dysautonomic or metabolic disorders.
Literature
1.
Tanzi R, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;3:344–50.CrossRef
2.
• Woimant F, Trocello J-M. Disorders of heavy metals. Elsevier, editor. Handb Clin Neurol. 2014;120:851–64. Insightful review of the current clinical, diagnostic, and treatment challenges in heavy metal disorders.CrossRef
3.
Poujois A, Woimant F. Wilson’s disease: a 2017 update. Clin Res Hepatol Gastroenterol 2018 (in press).
4.
Biswas S, Paul N, Das SK. Nonmotor manifestations of Wilson’s disease. Int Rev Neurobiol. 2017;134:1443–59.
5.
Giagheddu M, Tamburini G, Piga M, Tacconi P, Giagheddu A, Serra A, et al. Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson’s disease. Acta Neurol Scand. 2001;103:71–81.CrossRef
6.
Oder W, Prayer L, Grimm G, Spatt J, Ferenci P, Kollegger H, et al. Wilson’s disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology. 1993;43:120.CrossRef
7.
• Poujois A, Mikol J, Woimant F. Wilson disease: brain pathology. Handb Clin Neurol. 2017;142:77–89. A detailed review of macroscopic and microscopic neuropathological abnormalities described in Wilson’s disease and description of the distribution of copper in different parts of the brain.CrossRef
8.
Portala K, Westermark K, Ekselius L, Broman J-E. Sleep in patients with treated Wilson’s disease. A questionnaire study. Nord J Psychiatry. 2002;56:291–7.CrossRef
9.
• Nevsimalova S, Buskova J, Bruha R, Kemlink D, Sonka K, Vitek L, et al. Sleep disorders in Wilson’s disease. Eur J Neurol. 2011;18:184–90. The only study on sleep disorders in WD with objective measures on sleepinessCrossRef
10.
Netto A, Sinha S, Taly A, Panda S. Sleep in Wilson’s disease: questionnaire based study. Ann Indian Acad Neurol. 2011;14:31–4.PubMedPubMedCentral
11.
•• Trindade MC, Bittencourt T, Lorenzi-Filho G, Alves RC, de Andrade DC, Fonoff ET, et al. Restless legs syndrome in Wilson’s disease: frequency, characteristics, and mimics. Acta Neurol Scand. 2017;135:211–8. Interesting study focusing on RLS in WD.CrossRef
12.
•• Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, et al. Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med. 2016;17:179–85. Interesting study focusing on RBD in WD.CrossRef
13.
Netto A, Sinha S, Taly A, Panda S, Rao S. Sleep in Wilson’s disease: a polysomnography-based study. Neurol India. 2010;58:933.CrossRef
14.
American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. 2014; (Darien, IL American Academy of Sleep Medicine).
15.
De Cruz S, Espiritu J, Zeidler M, Wang T. Sleep disorders in chronic liver disease. Semin Respir Crit Care Med. 2012;33:26–35.CrossRef
16.
Litwin T, Dusek P, Członkowska A. Symptomatic treatment of neurologic symptoms in Wilson disease. Handb Clin Neurol. 2017;142:211–23.CrossRef
17.
Akil M, Brewer G. Psychiatric and behavioral abnormalities in Wilson’s disease. Adv Neurol. 1995;65:171–8.PubMed
18.
Litwin T, Dusek P, Szafrański T, Dzieżyc K, Członkowska A, Rybakowski J. Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment. Ther Adv. 2018;8:199–211.CrossRef
19.
Dening TR, Berrios GE. Wilson’s disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry. 1989;46:1126–34.CrossRef
20.
Shanmugiah A, Sinha S, Taly AB, Prashanth LK, Tomar M, Arunodaya GR, et al. Psychiatric manifestations in Wilson’s disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci. 2008;20:81–5.CrossRef
21.
Guillaud O, Dumortier J, Sobesky R, Debray D, Wolf P, Vanlemmens C. Long term results of liver transplantation for Wilson’s disease: experience in France. J Hepatol. 2014;60:579–89.CrossRef
22.
Laurencin C, Brunet A-S, Dumortier J, Lion-François L, Thobois S, Mabrut J. Liver transplantation in Wilson’s disease with neurological impairment: evaluation in 4 patients. Eur Neurol. 2017;77:5–15.CrossRef
23.
Tarter R, Van Thiel D, Hegedus A, Schade R, Gavaler J, Starzl T. Neuropsychiatric status after liver transplantation. J Lab Clin Med. 1984;103:776–82.PubMedPubMedCentral
24.
Zimbrean P, Schilsky M. The spectrum of psychiatric symptoms in Wilson’s disease: treatment and prognostic considerations. Am J Psychiatry. 2015;172:1068–72.CrossRef
25.
Bergonzi P, Chiurulla C, Cianchetti, et al. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of l-dopa. Conflin Neurol. 1974;36:5–22.CrossRef
26.
Huang Z, Deng J, Borjigin J. A novel H28Y mutation in LEC rats leads to decreased NAT protein stability in vivo and in vitro. J Pineal Res. 2005;39:84–90.CrossRef
27.
Borjigin J, Payne A, Deng J, Li X, Wang M, Ovodenko B. A novel pineal night-specific ATPase encoded by the Wilson disease gene. J Neurosci. 1999;19:1018–26.CrossRef
28.
• Scheiber I, Mercer J, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. 2014;116:33–57. A general and comprehensive review of metabolism and functions of copper in brain.CrossRef
29.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540–5.CrossRef
30.
Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28:113–21.CrossRef
31.
Firneisz G, Szlay F, Halasz P, Komoly S. Hypersomnia in Wilson’s disease : an unusual symptom in an unusual case. Acta Neurol Scand. 2000;101:286–8.CrossRef
32.
Amann VC, Maru NK, Jain V. Hypersomnolence in Wilson disease. J Clin Sleep Med. 2015;11:1341–3.CrossRef
33.
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria - history, rationale, description, and significance. Sleep Med. 2014;15:860–73.CrossRef
34.
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32.CrossRef
35.
Papapetripoulos S, Singer C. Painless legs moving toes in a patient with Wilson’s disease. Mov Disord. 2006;21:579–80.CrossRef
36.
• Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol. 2015;14:103–13. A comprehensive review of Wilson’s disease including its phenomenology, pathophysiology, imaging findings, and treatment.CrossRef
37.
Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M. Restless legs syndrome in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:S5–9.CrossRef
38.
De Cock VC, Bayard S, Yu H, Grini M, Carlander B, Postuma R, et al. Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson’s disease. Mov Disord. 2012;27:743–9.CrossRef
39.
Earley CJ, Connor J, Garcia-Borreguero D, Jenner P, Winkelman J, Zee PC, et al. Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease). Sleep Med. 2014;15:1288–301.CrossRef
40.
Connor JR, Wang XS, Allen RP, Beard JL, Wiesinger JA, Felt BT, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132:2403–12.CrossRef
41.
Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004;19:695–9.CrossRef
42.
Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. Am J Neuroradiol. 2003;24:234–8.PubMed
43.
García-Borreguero D, Williams A-M. An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment. Curr Opin Neurol. 2014;27:493–501.CrossRef
44.
Dusek P, Bahn E, Litwin T, Jabłonka-Salach K, Łuciuk A, Huelnhagen T, et al. Brain iron accumulation in Wilson disease: a post mortem 7 tesla MRI - histopathological study. Neuropathol Appl Neurobiol. 2017;43:514–32.CrossRef
45.
Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25:120–38.CrossRef
46.
Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51:526–9.CrossRef
47.
Kunz D, Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology. 1997;36:211–4.CrossRef
48.
Tribl GG, Bor-Seng-Shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson’s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr. 2014;72:653–8.CrossRef
Metadata
Title
Sleep Abnormalities in Wilson’s Disease
Authors
Valérie Cochen De Cock, MD, PhD
Nadège Girardot-Tinant, PhD
France Woimant, MD
Aurélia Poujois, MD, PhD
Publication date
01-11-2018
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 11/2018
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-018-0531-4

Other articles of this Issue 11/2018

Current Treatment Options in Neurology 11/2018 Go to the issue

Epilepsy (E Waterhouse, Section Editor)

Managing Antiepileptic Medication in Dialysis Patients

Epilepsy (E Waterhouse, Section Editor)

Sleep, Circadian Rhythms, and Epilepsy

Cerebrovascular Disorders (D Jamieson, Section Editor)

Stem Cell Therapy in Cerebrovascular Disease

Neuro-oncology (R Soffietti, Section Editor)

Novel Systemic Treatments for Brain Metastases From Lung Cancer